| ADT | Androgen Deprivation Therapy |
| BCR | Biochemical Recurrence |
| CI | Confidence Interval |
| CRPC | Castration-Resistant Prostate Cancer |
| CT | Computed Tomography |
| EAU | European Association of Urology |
| GTV | Gross Tumor Volume |
| HR | Hazard Ratio |
| ICECAP | Intermediate Clinical Endpoints of Cancer of the Prostate |
| IQR | Interquartile Range |
| ISUP | International Society of Urological Pathology |
| LN | Lymph Node |
| mCRPC | Metastatic Castration-Resistant Prostate Cancer |
| MDT | Metastasis-Directed Therapy |
| NA | Not Available |
| PCa | Prostate Cancer |
| PALN | Para-Aortic Lymph Node |
| PSA | Prostate-Specific Antigen |
| PSMA | Prostate Specific Membrane Antigen |
| PTV | Planning Target Volume |
| RP | Radical Prostatectomy |
| RT | Radiotherapy |
| SBRT | Stereotactic Body Radiation Therapy |
| SIB | Simultaneous Integrated Boost |
| sLND | Salvage Lymph Node Dissection/Salvage Lymphadenectomy |